Little Rock, ARNCT06634719Now EnrollingIRB Ready

Heavy Menstrual Bleeding Clinical Trial in Little Rock, AR

Access cutting-edge heavy menstrual bleeding treatment through this clinical trial at a research site in Little Rock. Study-provided care at no cost to qualified participants.

Sponsored by Rejoni Inc.

Quick Self-Assessment

See if you qualify for this Little Rock location

Preparing your pre-screening questions…

Expert Care in Little Rock

Access heavy menstrual bleeding specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related heavy menstrual bleeding treatment provided free

Apply for This Little Rock Location

Check if you qualify for this heavy menstrual bleeding clinical trial in Little Rock, AR

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Little Rock

    Convenient for AR residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Little Rock site if eligible
  4. 4Begin participation

About This Heavy Menstrual Bleeding Study in Little Rock

This is a prospective, multicenter, single-arm interventional feasibility study to evaluate the safety and feasibility of the Juveena Hydrogel System for temporary control of heavy menstrual bleeding (HMB) in women with a history of chronic ovulatory HMB.

Sponsor: Rejoni Inc.

Who Can Participate

Inclusion Criteria

Female aged 18 to 45 years inclusive seeking treatment for HMB
Recent history (within the last 3 months) of repeat periods of HMB that adversely affects quality of life (Modified SAMANTA score ≥4 and comprises at least three consecutive days of HMB, see Appendix 2).(23).
Historical menstrual pattern with at least 3 days (72 hours) of HMB as determined by retrospective MVJ Bleeding scale score of ≥5for prior cycle.
Menses frequency (24-38 days) based on subjectparticipant reporting.
Menses regularity - shortest to longest period is ≤8 days based on subjectparticipant reporting.
Actively experiencing heavy to very heavy menstrual bleeding (HMB) at the time of the Juveena HS treatment, i.e., MVJ score of ≥5 (treatment must be performed no later than Day 3 of the index period).
HMB refractory to hormone therapy, hormone therapy contraindicated, or subjectparticipant does not wish to continue hormone therapy.
The subjectparticipant is literate and clearly demonstrates an understanding of how to complete the MVJ Scale and other patient-reported outcomes.
Able and willing to comply with the study protocol and agrees to the following during participation in the study:
Use an effective non-hormonal method of birth control until the Day 28 visit. Acceptable methods of birth control for use in this study are abstinence and barrier contraceptives (e.g. condom)
No initiation or continuation of hormone use (including contraception) or any other medical intervention for bleeding until after the Day 28 visit (unless clinically necessary, e.g., the subjectparticipant becomes hemodynamically unstable)
Attends the follow-up examexams and completion of electronic diaries via a secured internet website (subject must have internet accesscompletes the MVJ scale and will be trained on how to use the eDiary)other patient-reported outcomes per the schedule of events
Demonstrates understanding of the study and signs the written informed consent form.

Exclusion Criteria

Pregnancy and/or breastfeeding within the past 3 months or planning to become pregnant during the duration of this study.
Currently using an intrauterine device (IUD) or has undergone removal within the last 2 menstrual cycles.
Dysmenorrhea of a severity that, in the opinion of the investigator, precludes participation in the study.
Hemoglobin of \< 8 g/dL at the time of screening.
Suspected or known malignancy or premalignant condition of the uterus including the cervix
Active pelvic infection.
Active sexually transmitted disease (STD) at the time of treatment (STD testing to be performed)
Presence of bacteremia, sepsis, or other active systemic infection
Currently on anticoagulants
History of allergies to PEG or FD\&C Blue#1 dye
Planning to undergo surgery or other treatments for HMB during the study period (i.e., 8 weeks post-hydrogel instillation).
AUB-L sm with a Type 0 or 1 leiomyoma \> 1 cm
AUB-P (Polyp) \> 2 cm in maximum dimension based on ultrasound, hysteroscopy, or MRI performed within prior 6 months.
AUB-O, Irregular menstrual cycles (cycle length variability \>7 days length)
AUB-C (coagulopathy or bleeding disorder)
Any patient who is currently participating or considering participation in any other research of an investigational drug or device. Does not include observational studies
Any general health, mental health, or social situation which, in the opinion of the investigator, could represent an increased risk for the patient or the ability of the patient to complete study requirements.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Little Rock?

Yes, this clinical trial (NCT06634719) has an active research site in Little Rock, AR that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Heavy Menstrual Bleeding Treatment Options in Little Rock, AR

If you're searching for heavy menstrual bleeding treatment options in Little Rock, AR, this clinical trial (NCT06634719) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Little Rock research site is actively enrolling participants for this clinical trial. You'll receive care from experienced heavy menstrual bleeding specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all heavy menstrual bleeding clinical trials near you to find additional studies recruiting in your area.

More Erectile Dysfunction Trials in Little Rock, AR

See all erectile dysfunction clinical trials recruiting in Little Rock — not just this study.

Browse Erectile Dysfunction Trials in Little Rock →

Browse More Trials by Condition

Erectile Dysfunction TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Little Rock?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Little Rock, AR